Zuowei Pei

601 total citations
38 papers, 455 citations indexed

About

Zuowei Pei is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Zuowei Pei has authored 38 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 10 papers in Complementary and alternative medicine. Recurrent topics in Zuowei Pei's work include Nigella sativa pharmacological applications (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Sirtuins and Resveratrol in Medicine (5 papers). Zuowei Pei is often cited by papers focused on Nigella sativa pharmacological applications (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Sirtuins and Resveratrol in Medicine (5 papers). Zuowei Pei collaborates with scholars based in China, Japan and United Kingdom. Zuowei Pei's co-authors include Jitsuo Higaki, Daijiro Enomoto, Ken‐ichi Miyoshi, Takafumi Okura, Tomoaki Nagao, Hongyang Liu, Masayoshi Kukida, Fang Wang, Ying Guo and Jun Irita and has published in prestigious journals such as Scientific Reports, RSC Advances and BioMed Research International.

In The Last Decade

Zuowei Pei

38 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuowei Pei China 13 125 110 78 67 49 38 455
Shuqing Shi China 14 166 1.3× 220 2.0× 46 0.6× 39 0.6× 52 1.1× 50 613
Bingxuan Zhang China 12 87 0.7× 115 1.0× 36 0.5× 64 1.0× 35 0.7× 28 358
Enchao Zhou China 12 65 0.5× 204 1.9× 44 0.6× 105 1.6× 44 0.9× 25 487
Fernando Grover‐Páez Mexico 9 115 0.9× 94 0.9× 29 0.4× 42 0.6× 23 0.5× 26 386
Ali A. Abo‐Saif Egypt 16 65 0.5× 168 1.5× 28 0.4× 34 0.5× 30 0.6× 37 593
Yiting He China 11 76 0.6× 114 1.0× 192 2.5× 63 0.9× 16 0.3× 32 482
Xiaomin Hou China 14 76 0.6× 166 1.5× 53 0.7× 28 0.4× 35 0.7× 59 523
Manuela Stoicescu Romania 13 99 0.8× 150 1.4× 32 0.4× 15 0.2× 27 0.6× 36 585
Giorgia Pierelli Italy 6 145 1.2× 156 1.4× 20 0.3× 86 1.3× 50 1.0× 7 494
Douglas Greig Chile 12 226 1.8× 64 0.6× 27 0.3× 49 0.7× 46 0.9× 35 401

Countries citing papers authored by Zuowei Pei

Since Specialization
Citations

This map shows the geographic impact of Zuowei Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuowei Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuowei Pei more than expected).

Fields of papers citing papers by Zuowei Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuowei Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuowei Pei. The network helps show where Zuowei Pei may publish in the future.

Co-authorship network of co-authors of Zuowei Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Zuowei Pei. A scholar is included among the top collaborators of Zuowei Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuowei Pei. Zuowei Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pei, Zuowei, et al.. (2024). Effects of Nicotinamide Adenine Dinucleotide on Older Patients with Heart Failure. Reviews in Cardiovascular Medicine. 25(8). 297–297. 1 indexed citations
2.
Pei, Zuowei, et al.. (2024). Regulation of Sirtuins in Sepsis-Induced Myocardial Damage: The Underlying Mechanisms for Cardioprotection. Frontiers in Bioscience-Landmark. 29(2). 54–54. 4 indexed citations
3.
4.
He, Q., et al.. (2023). Luteolin reduces cardiac damage caused by hyperlipidemia in Sprague-Dawley rats. Heliyon. 9(6). e17613–e17613. 11 indexed citations
5.
Pei, Zuowei, et al.. (2023). Different exercise training intensities prevent type 2 diabetes mellitus-induced myocardial injury in male mice. iScience. 26(7). 107080–107080. 3 indexed citations
6.
Dong, Min, Shuo Wang, & Zuowei Pei. (2023). Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease. International Journal of Medical Sciences. 20(2). 262–266. 6 indexed citations
7.
Pei, Zuowei, et al.. (2023). NAD+: A key metabolic regulator with great therapeutic potential for myocardial infarction via Sirtuins family. Heliyon. 9(11). e21890–e21890. 2 indexed citations
8.
Jiang, Bo, et al.. (2021). The Role of Exercise in Reducing Hyperlipidemia‐Induced Neuronal Damage in Apolipoprotein E‐Deficient Mice. BioMed Research International. 2021(1). 5512518–5512518. 8 indexed citations
9.
Pei, Zuowei, et al.. (2021). Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2021(1). 3899356–3899356. 2 indexed citations
10.
Guo, Ying, Xiang Wang, Chenguang Yang, et al.. (2021). Myocardial Work by Speckle Tracking Echocardiography Accurately Assesses Left Ventricular Function of Coronary Artery Disease Patients. Frontiers in Cardiovascular Medicine. 8. 727389–727389. 14 indexed citations
11.
Xu, Jingyi, Zuowei Pei, Xiang Li, et al.. (2020). Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High‐Cholesterol Diet‐Induced Chronic Kidney Disease in ApoE‐Deficient Mice. BioMed Research International. 2020(1). 1809326–1809326. 1 indexed citations
12.
13.
Zhang, Xiaoqing, et al.. (2018). Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice. Lipids in Health and Disease. 17(1). 279–279. 29 indexed citations
14.
Xu, Jingyi, et al.. (2018). Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice. Lipids in Health and Disease. 17(1). 173–173. 23 indexed citations
15.
Liu, Hongyang, Yan Sun, Ying Zhang, et al.. (2018). Role of Thymoquinone in Cardiac Damage Caused by Sepsis from BALB/c Mice. Inflammation. 42(2). 516–525. 23 indexed citations
16.
Zhang, Ying, Nan Wang, Zuowei Pei, et al.. (2017). The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Reduces Aortic Damage from Hypercholesterolaemia in Apolipoprotein E-Deficient Mice. PubMed. 2(2). 1–9. 3 indexed citations
17.
Pei, Zuowei, Takafumi Okura, Tomoaki Nagao, et al.. (2016). Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice. Scientific Reports. 6(1). 28882–28882. 22 indexed citations
18.
Okura, Takafumi, Ken‐ichi Miyoshi, Jun Irita, et al.. (2014). Carotid hemodynamics is associated with monocyte count determined by serum homocysteine level in patients with essential hypertension. Clinical and Experimental Hypertension. 37(5). 358–363. 4 indexed citations
19.
Okura, Takafumi, Ken‐ichi Miyoshi, Jun Irita, et al.. (2014). Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Scientific Reports. 4(1). 5663–5663. 47 indexed citations
20.
Okura, Takafumi, Jun Irita, Daijiro Enomoto, et al.. (2010). Association between cystatin C and inflammation in patients with essential hypertension. Clinical and Experimental Nephrology. 14(6). 584–588. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuqing Shi Breakdown of academic impact, for papers by Bingxuan Zhang Breakdown of academic impact, for papers by Enchao Zhou Breakdown of academic impact, for papers by Fernando Grover‐Páez Breakdown of academic impact, for papers by Ali A. Abo‐Saif Breakdown of academic impact, for papers by Yiting He Breakdown of academic impact, for papers by Xiaomin Hou Breakdown of academic impact, for papers by Manuela Stoicescu Breakdown of academic impact, for papers by Giorgia Pierelli Breakdown of academic impact, for papers by Douglas Greig
Rankless by CCL
2026